SLPI and bacterial infectious disease: Neutrophil elastase inhibitor therapy also augmented RV-induction of the antimicrobial peptide secretory leucocyte protease inhibitor (SLPI) (Fig. 5H), a protein we have previously shown to drive secondary bacterial infection during virus exacerbated COPD2,23.